Novel prodrugs of estradiol
The present invention is a prodrug derivative of estradiol according to Formula I:
1 . A prodrug derivative of estradiol having the following formula:
and enantiomers and pharmaceutically acceptable salts thereof, wherein X is selected from the group consisting of
2 . The prodrug of claim 1 , wherein X is
3 . A pharmaceutical dosage unit comprising:
(a) a prodrug derivative of estradiol having the following formula:
and enantiomers and pharmaceutically acceptable salts thereof, wherein X is selected from the group consisting of
and
(b) one or more pharmaceutically acceptable excipients.
4 . A method of providing contraception comprising the step of:
administering to a patient in need thereof, an effective amount of said prodrug derivative of estradiol of claim 1 , for an effective period of time.
5 . A method of providing hormone treatment therapy to a patient in need thereof, comprising the step of:
administering to said patient in need thereof, an effective amount of said prodrug derivative of estradiol of claim 1 , for an effective period of time.